| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |